DENTSPLY SIRONA Inc.
Here’s whether DENTSPLY SIRONA Inc. (XRAY) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.79% over 10 days); RSI 56 — healthy momentum range; 3-month momentum positive (+8.6%). Concerns: weak 1-year return of -21.4%. Currently 23.2% off its 52-week high. Score: +5/7.
XRAY is in a confirmed uptrend, trading above both its 50-day ($11.05) and 200-day ($11.77) moving averages. An RSI of 56.2 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -21.4% compares to +16.5% for SPY (trailed the market by 37.9%). The current 23.2% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.